BMY — Bristol-Myers Squibb

Health Care · NYSE/Nasdaq. Last price 58.83 USD (+0.84% on the day). Raven's AI 12-month target: 62.50 USD. Updated 2026-11-20.

Paper-trade Bristol-Myers Squibb free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 62.50 USD (+7.13% from 58.34 when it was set on 2026-11-20). Conviction: medium.

Catalysts: Pipeline clinical data; Dividend sustainability; M&A optionality

Risks: Regulatory headwinds on pricing; Patent cliff risk; Clinical trial delays

Earnings

Q3 2026 earnings per share: 1.35 USD against 1.17 expected (beat by 15.2%). EPS estimates for 2026: 6.45 USD (27 analysts), 2027: 6.70 USD (28 analysts). The 2026 estimate has moved -7.2% over 90 days.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · AMGN Amgen · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical · JNJ Johnson & Johnson

RAVEN is taking longer than usual to load.
RELOAD